logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.

    • Opioid Antagonist class drugs

    FiltersReset Filters
    29 results

    • buprenorphine and naloxone

      (Buprenorphine and Naloxone)
      Sun Pharmaceutical Industries, Inc.
      Usage: Buprenorphine and naloxone sublingual tablet is indicated for the maintenance treatment of opioid dependence. It should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.

    • buprenorphine and naloxone

      (Buprenorphine and Naloxone)
      Rhodes Pharmaceuticals L.P.
      Usage: Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence, and should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.

    • buprenorphine and naloxone

      (Buprenorphine and Naloxone)
      Dr.Reddys Laboratories Inc
      Usage: Buprenorphine and naloxone sublingual film is indicated for the treatment of opioid dependence, to be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.

    • buprenorphine and naloxone

      (Buprenorphine and Naloxone)
      Dr.Reddys Laboratories Inc
      Usage: Buprenorphine and naloxone sublingual film is indicated for the treatment of opioid dependence and should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.

    • buprenorphine and naloxone

      (Buprenorphine and Naloxone)
      Actavis Pharma, Inc.
      Usage: Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence, and should be used as part of a comprehensive treatment plan that includes counseling and psychosocial support.

    • buprenorphine and naloxone

      (Buprenorphine and Naloxone)
      Lannett Company, Inc.
      Usage: Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence, to be used alongside a comprehensive treatment plan that includes counseling and psychosocial support.

    • buprenorphine hcl and naloxone hcl

      (Buprenorphine and Naloxone)
      Amneal Pharmaceuticals LLC
      Usage: Buprenorphine and Naloxone Sublingual Tablets are indicated for the maintenance treatment of opioid dependence and should be used alongside a comprehensive treatment plan that includes counseling and psychosocial support.

    • buprenorphine hydrochloride and naloxone hydrochloride dihydrate

      (buprenorphine hydrochloride and naloxone hydrochloride dihydrate)
      Hikma Pharmaceuticals USA Inc.
      Usage: Buprenorphine and Naloxone Sublingual Tablets are indicated for the maintenance treatment of opioid dependence, to be used alongside a comprehensive treatment plan that includes counseling and psychosocial support.

    • buprenorphine hydrochloride and naloxone hydrochloride dihydrate

      (Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate)
      SpecGx LLC
      Usage: Buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence, and should be used in conjunction with a comprehensive treatment plan that includes counseling and psychosocial support.

    • contrave

      (naltrexone hydrochloride and bupropion hydrochloride)
      Nalpropion Pharmaceuticals LLC
      Usage: CONTRAVE is indicated for chronic weight management in adults with a BMI of 30 kg/m² or greater (obese) or 27 kg/m² or greater (overweight) with weight-related comorbid conditions, as an adjunct to diet and exercise. Safety with other weight loss products is not established.